Twist Bioscience (TWST) Capital Expenditures (2017 - 2025)
Historic Capital Expenditures for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $10.0 million.
- Twist Bioscience's Capital Expenditures rose 33977.07% to $10.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $35.7 million, marking a year-over-year increase of 51168.21%. This contributed to the annual value of $28.0 million for FY2025, which is 45169.42% up from last year.
- Per Twist Bioscience's latest filing, its Capital Expenditures stood at $10.0 million for Q4 2025, which was up 33977.07% from $12.4 million recorded in Q3 2025.
- In the past 5 years, Twist Bioscience's Capital Expenditures registered a high of $40.6 million during Q2 2022, and its lowest value of $603000.0 during Q1 2024.
- Its 5-year average for Capital Expenditures is $9.8 million, with a median of $8.2 million in 2021.
- In the last 5 years, Twist Bioscience's Capital Expenditures crashed by 9333.92% in 2024 and then skyrocketed by 84974.09% in 2025.
- Over the past 5 years, Twist Bioscience's Capital Expenditures (Quarter) stood at $12.8 million in 2021, then decreased by 7.5% to $11.8 million in 2022, then plummeted by 87.26% to $1.5 million in 2023, then soared by 50.6% to $2.3 million in 2024, then skyrocketed by 339.77% to $10.0 million in 2025.
- Its Capital Expenditures was $10.0 million in Q4 2025, compared to $12.4 million in Q3 2025 and $9.2 million in Q2 2025.